Page last updated: 2024-10-24

chlorambucil and Granulomatosis, Orofacial

chlorambucil has been researched along with Granulomatosis, Orofacial in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Granulomatosis, Orofacial: A condition characterized by persistent or recurrent labial enlargement, ORAL ULCER, and other orofacial manifestations in the absence of identifiable CROHN DISEASE; or SARCOIDOSIS. Among experts there is disagreement on whether orofacial granulomatosis is a distinct clinical disorder or an initial presentation of Crohn disease.

Research Excerpts

ExcerptRelevanceReference
"We present a case of oral mucosal MALT lymphoma with clinical features simulating oral-facial granulomatosis."1.34Oral mucosal MALT lymphoma clinically simulating oral facial granulomatosis. ( Gerami, P, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gerami, P1

Other Studies

1 other study available for chlorambucil and Granulomatosis, Orofacial

ArticleYear
Oral mucosal MALT lymphoma clinically simulating oral facial granulomatosis.
    International journal of dermatology, 2007, Volume: 46, Issue:8

    Topics: Antineoplastic Agents, Alkylating; Chlorambucil; Diagnosis, Differential; Female; Granulomatosis, Or

2007